All In Biotech

Drug Trial Radar · NCT04893239

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

Last checked: Nov 19, 2026Latest source record: Mar 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

Aug 18, 2021

Primary completion

Feb 23, 2022

Study completion Feb 23, 2022

Sponsor

Lead sponsor
Lumen Bioscience, Inc.Industry
Sponsor type
Industry
First posted
May 19, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a Phase 1, single-site, open label, exploratory study to assess delivery of LMN-201 components via enteric capsules in the gut of individuals with ostomies.

Conditions

  • C. Diff. Infections

Interventions

  • LMN-201 Anti-toxin B VHH-1Biological

    Components of LMN-201

  • LMN-201 Anti-toxin B VHH-2Biological

    Components of LMN-201

  • LMN-201 Anti-toxin B VHH-3Biological

    Components of LMN-201

  • LMN-201 Anti-toxin B VHH-1, VHH-2, VHH-3Biological

    Components of LMN-201

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Presence of Capsules and/or Transit Markers in Ostomy Fluid by Visual ObservationTime frame: Arrival (baseline), Predose (immediately before dosing), and up to 12 hours post dose.

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Wesley Medical Research Limited

    Auchenflower, Queensland, Australia

  • Coastal Digestive Health

    Maroochydore, Queensland, Australia

  • Coral Sea Clinical Research Institute

    North Mackay, Queensland, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.